Skip to main content
Log in

Alpelisib/toripalimab

Diabetes mellitus and drug misuse: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Gao Y, et al. Immune checkpoint inhibitor- and phosphatidylinositol-3-kinase inhibitor-related diabetes induced by antineoplastic drugs: two case reports and a literature review. Frontiers in Endocrinology 14: 2023. Available from: URL: https://www.frontiersin.org/journals/endocrinology#

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alpelisib/toripalimab. Reactions Weekly 1985, 35 (2023). https://doi.org/10.1007/s40278-023-50805-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-50805-2

Navigation